Larimar Therapeutics, Inc. (LRMR)

CIK 1374690 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Larimar Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Aug 4, 202610-Q0001193125-26-331529
Aug 4, 20268-K0001193125-26-331516
Jul 8, 202640001193125-26-298523
Jun 29, 20268-K0001193125-26-286780
May 20, 202640001193125-26-232644
May 20, 202640001193125-26-232705
May 20, 202640001193125-26-232667
May 20, 202640001193125-26-232657
May 20, 202640001193125-26-232933
May 20, 202640001193805-26-000669
May 19, 20268-K0001193125-26-230852
May 14, 20268-K0001193125-26-222746
May 14, 202610-Q0001193125-26-224087
May 14, 2026SCHEDULE 13G/A0001140361-26-021322
Apr 30, 2026SCHEDULE 13G/A0001104659-26-053218
Apr 20, 2026DEF 14A0001193125-26-163942
Apr 20, 2026ARS0001193125-26-163954
Apr 10, 2026PRE 14A0001193125-26-151258
Mar 19, 2026S-80001193125-26-116159
Mar 19, 202610-K0001193125-26-115878
Mar 19, 20268-K0001193125-26-115119
Mar 9, 20268-K0001193125-26-098493
Mar 2, 202640001193125-26-085514
Mar 2, 202640001193125-26-085510
Mar 2, 2026SCHEDULE 13D/A0001193805-26-000206